A brief shouldn't be misleading.Oversubscribed funding.
Much appreciated oversubscribed investors. Thank you.
From the article:
Though the company described the round as “oversubscribed,” the $22 million falls far short of the $125 million that the company was reportedly seeking. Adam Rodman, chief investment officer at Segra Capital, told The Globe and Mail that the $22 million was “the least amount of capital possible” to help the company hit the next scientific milestone.
Last edited:






